GSK boosts board-level science as new CEO prepares to take over

Drugmaker GlaxoSmithKline is bolstering scientific expertise on its board by establishing a new science committee, charged with overseeing research, as a new chief executive prepares to take over. Incoming CEO Emma Walmsley, the first woman to lead a top global drugmaker, stands out among Big Pharma bosses as a consumer brands specialist rather than a prescription medicines expert. Since her appointment in September she has spent much of her time learning about GSK's prescription drug research a